The FDA has provided clearance for Siemens SOMATOM portfolio of CT scanners for low-dose lung cancer screening.
The U.S. FDA has cleared the SOMATOM CT systems by Siemens Healthcare for low-dose lung cancer screening, Siemens announced last week.
All of Siemens new CT scanners, as well as the company’s installed base of non-end-of-support systems use standard low-dose lung protocols already delivered on the scanners, Siemens said in a release. Automated settings in the Siemens’ portfolio, like reducing user variability, and setting an optimum range for scan settings that avoids cut-offs or excessive radiation, optimize the low-dose lung cancer screening workflow, Siemens said.
Siemens has also launched a mobile imaging solution for lung cancer screening aimed for people living in rural areas, the company announced. The mobile SOMATOM Scope CT is a self-powered mobile CT with an on-board diesel generator that is ready to scan “within minutes” of parking and is equipped with a high-speed wireless connection, Siemens said.
The indication for low-dose lung cancer screening is available for the following CT systems: SOMATOM Force, SOMATOM Definition Flash, SOMATOM Definition Edge, SOMATOM Definition AS/AS+, SOMATOM Perspective, SOMATOM Scope, and the SOMATOM Emotion 16.
[[{"type":"media","view_mode":"media_crop","fid":"43954","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_4646017352372","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4885","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Image provided courtesy of Siemens Healthcare.","typeof":"foaf:Image"}}]]
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.